Sage Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
26.03.24
/
50%
€17.20
Target price
26.03.25
€26.71
Performance (%)
-29.30%
Price
09:21
€12.07
Summary
This prediction is currently active. The prediction for Sage Therapeutics Inc. disappoints with a performance of -29.30%. This prediction currently runs until 26.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sage Therapeutics Inc. | -7.586% | -7.586% |
iShares Core DAX® | 2.831% | 1.236% |
iShares Nasdaq 100 | 2.918% | 0.640% |
iShares Nikkei 225® | 2.007% | -2.135% |
iShares S&P 500 | 2.257% | 0.451% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target raised by analysts at JPMorgan Chase & Co. from $24.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.59
01.05.24
01.05.24
€26.21
01.05.25
01.05.25
-4.17%
09:21
09:21